ABBOTT LABORATORIES Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2012 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Abbott Laboratories quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2012 to Q2 2024.
  • Abbott Laboratories Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was $1.3B, a 5.31% decline year-over-year.
  • Abbott Laboratories Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was $5.56B, a 7.67% increase year-over-year.
  • Abbott Laboratories annual Net Income (Loss) Attributable to Parent for 2023 was $5.72B, a 17.5% decline from 2022.
  • Abbott Laboratories annual Net Income (Loss) Attributable to Parent for 2022 was $6.93B, a 1.95% decline from 2021.
  • Abbott Laboratories annual Net Income (Loss) Attributable to Parent for 2021 was $7.07B, a 57.3% increase from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $5.56B $1.3B -$73M -5.31% Apr 1, 2024 Jun 30, 2024 10-Q 2024-07-31
Q1 2024 $5.63B $1.23B -$93M -7.06% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-02
Q4 2023 $5.72B $1.59B +$561M +54.3% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-16
Q3 2023 $5.16B $1.44B +$1M +0.07% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-01
Q2 2023 $5.16B $1.38B -$643M -31.9% Apr 1, 2023 Jun 30, 2023 10-Q 2024-07-31
Q1 2023 $5.8B $1.32B -$1.13B -46.1% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q4 2022 $6.93B $1.03B -$956M -48.1% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-16
Q3 2022 $7.89B $1.44B -$665M -31.7% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-01
Q2 2022 $8.55B $2.02B +$829M +69.7% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 $7.73B $2.45B +$654M +36.5% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 $7.07B $1.99B -$173M -8% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-16
Q3 2021 $7.24B $2.1B +$868M +70.5% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-01
Q2 2021 $6.38B $1.19B +$652M +121% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-02
Q1 2021 $5.72B $1.79B +$1.23B +218% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-03
Q4 2020 $4.5B $2.16B +$1.11B +106% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-17
Q3 2020 $3.38B $1.23B +$272M +28.3% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-03
Q2 2020 $3.11B $537M -$469M -46.6% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-04
Q1 2020 $3.58B $564M -$108M -16.1% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q4 2019 $3.69B $1.05B +$395M +60.4% Oct 1, 2019 Dec 31, 2019 10-K 2020-02-21
Q3 2019 $3.29B $960M +$397M +70.5% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-04
Q2 2019 $2.9B $1.01B +$273M +37.2% Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-29
Q1 2019 $2.62B $672M +$254M +60.8% Jan 1, 2019 Mar 31, 2019 10-Q 2020-04-29
Q4 2018 $2.37B $654M +$1.48B Oct 1, 2018 Dec 31, 2018 10-K 2020-02-21
Q3 2018 $886M $563M -$40M -6.63% Jul 1, 2018 Sep 30, 2018 10-K 2020-02-21
Q2 2018 $926M $733M +$450M +159% Apr 1, 2018 Jun 30, 2018 10-K 2020-02-21
Q1 2018 $476M $418M -$1M -0.24% Jan 1, 2018 Mar 31, 2018 10-K 2020-02-21
Q4 2017 $477M -$828M -$1.63B -204% Oct 1, 2017 Dec 31, 2017 10-K 2019-02-22
Q3 2017 $2.1B $603M +$932M Jul 1, 2017 Sep 30, 2017 10-K 2019-02-22
Q2 2017 $1.17B $283M -$332M -54% Apr 1, 2017 Jun 30, 2017 10-K 2019-02-22
Q1 2017 $1.5B $419M +$103M +32.6% Jan 1, 2017 Mar 31, 2017 10-K 2019-02-22
Q4 2016 $1.4B $798M +$31M +4.04% Oct 1, 2016 Dec 31, 2016 10-K 2018-02-16
Q3 2016 $1.37B -$329M -$909M -157% Jul 1, 2016 Sep 30, 2016 10-K 2018-02-16
Q2 2016 $2.28B $615M -$169M -21.6% Apr 1, 2016 Jun 30, 2016 10-K 2018-02-16
Q1 2016 $2.45B $316M -$1.98B -86.2% Jan 1, 2016 Mar 31, 2016 10-K 2018-02-16
Q4 2015 $4.42B $767M -$138M -15.2% Oct 1, 2015 Dec 31, 2015 10-K 2017-02-17
Q3 2015 $4.56B $580M +$42M +7.81% Jul 1, 2015 Sep 30, 2015 10-K 2017-02-17
Q2 2015 $4.52B $784M +$318M +68.2% Apr 1, 2015 Jun 30, 2015 10-K 2017-02-17
Q1 2015 $4.2B $2.29B +$1.92B +511% Jan 1, 2015 Mar 31, 2015 10-K 2017-02-17
Q4 2014 $2.28B $905M +$316M +53.7% Oct 1, 2014 Dec 31, 2014 10-K 2016-02-19
Q3 2014 $1.97B $538M -$428M -44.3% Jul 1, 2014 Sep 30, 2014 10-K 2016-02-19
Q2 2014 $2.4B $466M -$10M -2.1% Apr 1, 2014 Jun 30, 2014 10-K 2016-02-19
Q1 2014 $2.41B $375M -$170M -31.2% Jan 1, 2014 Mar 31, 2014 10-K 2016-02-19
Q4 2013 $2.58B $589M -$464M -44.1% Oct 1, 2013 Dec 31, 2013 10-K 2015-02-27
Q3 2013 $3.04B $966M -$977M -50.3% Jul 1, 2013 Sep 30, 2013 10-K 2015-02-27
Q2 2013 $4.02B $476M -$1.25B -72.4% Apr 1, 2013 Jun 30, 2013 10-K 2015-02-27
Q1 2013 $5.27B $545M -$697M -56.1% Jan 1, 2013 Mar 31, 2013 10-K 2015-02-27
Q4 2012 $5.96B $1.05B Oct 1, 2012 Dec 31, 2012 10-K 2014-02-21
Q3 2012 $1.94B Jul 1, 2012 Sep 30, 2012 10-K 2014-02-21
Q2 2012 $1.73B Apr 1, 2012 Jun 30, 2012 10-K 2014-02-21
Q1 2012 $1.24B Jan 1, 2012 Mar 31, 2012 10-K 2014-02-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.